Investigators studied expression of type I interferons, key pathogenic drivers in systemic lupus erythematosus and lupus nephritis.

When a rhinovirus, the most frequent cause of the common cold, infects the lining of our nasal passages, our cells work ...

Cold severity hinges on nasal immune timing, with fast interferon release stopping rhinovirus early and delayed responses allowing widespread infection and symptoms.

A new study shows that the body’s early immune response, not the virus itself, often determines how severe a rhinovirus cold ...

Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

Treatment of COVID-19 with interferon beta-1b — even for just a few days, a much shorter period than is commonly used for maintenance in multiple sclerosis (MS), for example — is associated with ...

During a bout of influenza, B cells interact with other immune cells and then take different paths to defend the body. One path is the B cells that differentiate into lung-resident memory B cells, or ...

Interferon therapies are well established as treatment options for some types of cancer, but they have not been used to treat cancers characterized by the overproduction of blood cells. The FDA has ...